Our team has more than five decades of experience in clinical medicine and human health and it's all focused on providing you with cannabinoid products you can trust. We are developing clinically-tested CBD products that combine hemp oil extract in technologically-advanced formulations to deliver real results, fast. For you, that means relief, reliability and safety.
AND WE ARE OPTIMIZING CANNABINOIDS. Powered by the vision of physicians, pharmacists, researchers and natural product industry leaders, we are optimizing the most effective cannabinoid products on the market.CBD products that combine hemp oil extract in technologically-advanced formulations to deliver real results, fast. For you, that means relief, reliability and safety.
Our R&D is focused on maximizing the optimal ratios of cannabinoids and terpenes, in combination with our patented delivery technology, VESIsorb®. For over a decade, close to 200 million consumers on six continents have safely and effectively used VESIsorb formulations.
In a recent peer reviewed scientific journal, our CBD soft-gel capsules showed the best clinical trial results with over 4X the bioavailability vs other conventional CBD products.
At OptiCann, scientific research is the starting point
for every product we develop.
Toronto, ON, August 5, 2020 – Heritage Cannabis to Acquire Colorado-based Opticann Inc. Founded by former MedReleaf executives, Opticann provides strategic access to the rapidly growing multi-billion dollar U.S. CBD market.
Did you know that humans have a system that produces cannabis-like compounds and regulates how cannabinoids like cannabidiol (CBD) interact with the body? This is the mechanism that explains how CBD may offer therapeutic effects.
Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The identification of cannabinoid receptors and their endogenous ligands, has led to a significant growth in research aimed at understanding the physiological functions of cannabinoids.